Protein,Protein_definition,Disease_category,Disease,method,nsnp,OR [95% CI],Pvalue,QTL_type
APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,Chapter X Diseases of the respiratory system,J10_LOWCHRON,Inverse variance weighted,61,1.1 [1.05-1.15],2.73084917010134e-05,trans
APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,Chapter X Diseases of the respiratory system,J10_ASTHMA_EXMORE,Inverse variance weighted,59,1.05 [1.01-1.1],0.0113939369433149,trans
APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,Inverse variance weighted,69,1.02 [0.99-1.05],0.21494974150415,trans
APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,Chapter X Diseases of the respiratory system,J10_INFLUPNEU,Inverse variance weighted,3,1.06 [0.86-1.29],0.596623562793839,trans
APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,Chapter II Neoplasms,C3_CLL_EXALLC,Inverse variance weighted,4,1 [0.98-1.02],0.768728571459467,trans
APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,Chapter X Diseases of the respiratory system,J10_PNEUMONAS,Wald ratio,1,0.98 [0.79-1.22],0.839056421540574,trans
APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,Chapter II Neoplasms,CD2_LYMPHOID_LEUKAEMIA_EXALLC,Inverse variance weighted,8,1 [0.97-1.02],0.877347661620363,trans
